It's clear to the CAMH longs that STJ has in place a strategy for using MTWA as a catalyst for increased ICD sales via developing a more thorough screening program.
Today's CAMH drop below $4 is a disappointment to the faithful, but I see it as a great buying opportunity. For those on the fence, the CC is a must listen.